{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:23:03Z","timestamp":1787772183006,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To estimate the frequency and characteristics of Latent Autoimmune Diabetes in Adults (LADA) in patients diagnosed with type 2 diabetes mellitus (T2DM) at a single diabetes center in Medina, Saudi Arabia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This was a cross-sectional study involving patients with T2DM aged 30\u201370 years with a disease duration of \u22645 years, and who had not received insulin for at least 6 months post-T2DM diagnosis. Demographics, anthropometrics, autoantibodies to Glutamic Acid Decarboxylase Autoantibodies (GADA) and islet cell antibodies (ICA), serum C-peptide, glycated hemoglobin (HbA1C), and lipid data were collected. LADA was diagnosed according to GADA and\/or ICA positivity. Participants were classified into two groups: LADA and non-LADA. The clinical and biochemical characteristics of both groups were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 157 participants (mean age 50 years, 52.9% male) were enrolled, with 30 (19.1%) testing positive for GADA and\/or ICA. Among them, 16 (10.2%) were positive for GADA alone, 9 (5.7%) tested positive for ICA alone, and 5 (3.2%) tested positive for both GADA and ICA. GADA was significantly more prevalent in younger individuals (30\u201349 years,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02) and males, who also had higher rates of dual autoantibodies compared to females (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03). LADA patients had a significantly shorter duration of diabetes, along with lower body mass index, C-peptide, and triglyceride levels, but exhibited higher HbA1c and greater insulin use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The study reveals a high rate of LADA within this cohort of Saudi patients diagnosed with T2DM. LADA patients display some clinical and biochemical characteristics that set them apart from conventional T2DM cases. Screening for \u03b2-cell autoantibodies in individuals with these features could aid in earlier diagnosis of LADA and allow for more tailored treatment approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jrms.jrms_438_25","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:00:09Z","timestamp":1778648409000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Latent autoimmune diabetes mellitus and its characteristics amongst adults diagnosed with type 2 diabetes at a single diabetes center in Medina, Saudi Arabia"],"prefix":"10.4103","volume":"31","author":[{"given":"Eman","family":"Alfadhli","sequence":"first","affiliation":[{"name":"Medicine Department, College of Medicine, Taibah University, Madina, Saudi Arabia"},{"name":"Medicine Department, King Faisal Specialist Hospital & Research Center, Madina, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Mohammedsaeed","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Sciences Department, Faculty of Applied Medical Science, Taibah University, Medina, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Surrati","sequence":"additional","affiliation":[{"name":"Family, Community Medicine and Medical Education Department, College of Medicine, Taibah University, Medina, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashael","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Diabetes Center Department, AL-Iman General Hospital, Riyadh First Health Cluster, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Diabetes Center Department, King Fahd Hospital, Medina, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Endocrinology Department, King Salman Medical City, Medina, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3]]},"reference":[{"key":"R1-20260618","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4158\/EP.7.5.339","article-title":"Autoantibodies to IA-2 and GAD65 in patients with type 2 diabetes mellitus of varied duration: Prevalence and correlation with clinical features","volume":"7","author":"Grasso","year":"2001","journal-title":"Endocr Pract"},{"key":"R2-20260618","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4093\/dmj.2012.36.2.116","article-title":"Latent autoimmune diabetes in adults:Autoimmune diabetes in adults with slowly progressive \u03b2-cell failure","volume":"36","author":"Seok","year":"2012","journal-title":"Diabetes Metab J"},{"key":"R3-20260618","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/meta.2001.25654","article-title":"Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1 (1\/2) diabetes in patients presenting with type 2 diabetes","volume":"50","author":"Juneja","year":"2001","journal-title":"Metabolism"},{"key":"R4-20260618","doi-asserted-by":"crossref","first-page":"e3205","DOI":"10.1002\/dmrr.3205","article-title":"Past, present and future of latent autoimmune diabetes in adults","volume":"36","author":"Liu","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"R5-20260618","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12020-023-03424-5","article-title":"The worldwide prevalence of latent autoimmune diabetes of adults among adult-onset diabetic individuals: A systematic review and meta-analysis","volume":"82","author":"Ramu","year":"2023","journal-title":"Endocrine"},{"issue":"Suppl 2","key":"R6-20260618","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.2337\/dc09-S317","article-title":"Beta-cell protection and therapy for latent autoimmune diabetes in adults","volume":"32","author":"Cernea","year":"2009","journal-title":"Diabetes Care"},{"key":"R7-20260618","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/sjmms.sjmms_394_22","article-title":"Prevalence of type 2 diabetes mellitus in the general population of Saudi Arabia, 2000-2020: A systematic review and meta-analysis of observational studies","volume":"11","author":"Jarrar","year":"2023","journal-title":"Saudi J Med Med Sci"},{"key":"R8-20260618","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1464-5491.2005.01438.x","article-title":"Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients","volume":"22","author":"Damanhouri","year":"2005","journal-title":"Diabet Med"},{"key":"R12-20260618","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2337\/dc05-2101","article-title":"A clinical screening tool identifies autoimmune diabetes in adults","volume":"29","author":"Fourlanos","year":"2006","journal-title":"Diabetes Care"},{"key":"R13-20260618","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2337\/dc12-0931","article-title":"Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7","volume":"36","author":"Hawa","year":"2013","journal-title":"Diabetes Care"},{"key":"R14-20260618","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/diabetes.48.1.150","article-title":"Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies","volume":"48","author":"Tuomi","year":"1999","journal-title":"Diabetes"},{"key":"R15-20260618","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2337\/dbi20-0017","article-title":"Management of latent autoimmune diabetes in adults:A consensus statement from an international expert panel","volume":"69","author":"Buzzetti","year":"2020","journal-title":"Diabetes"},{"key":"R16-20260618","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(97)03062-6","article-title":"UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group","volume":"350","author":"Turner","year":"1997","journal-title":"Lancet"},{"key":"R17-20260618","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.2337\/diabetes.51.6.1754","article-title":"A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes","volume":"51","author":"Borg","year":"2002","journal-title":"Diabetes"},{"key":"R18-20260618","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrendo.2017.99","article-title":"Adult-onset autoimmune diabetes:Current knowledge and implications for management","volume":"13","author":"Buzzetti","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"R19-20260618","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1464-5491.1994.tb00327.x","article-title":"Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark","volume":"11","author":"M\u00f8lbak","year":"1994","journal-title":"Diabet Med"},{"key":"R20-20260618","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2337\/diab.42.2.359","article-title":"Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease","volume":"42","author":"Tuomi","year":"1993","journal-title":"Diabetes"},{"key":"R21-20260618","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/dmrr.2411","article-title":"Action LADA 8. Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain","volume":"29","author":"Mollo","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"R22-20260618","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/dc14-1770","article-title":"Latent autoimmune diabetes in adults with low-titer GAD antibodies:Similar disease progression with type 2 diabetes:A nationwide, multicenter prospective study (LADA China study 3)","volume":"38","author":"Liu","year":"2015","journal-title":"Diabetes Care"}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.jrms_438_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:30:35Z","timestamp":1787769035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.jrms_438_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jrms.jrms_438_25","relation":{},"ISSN":["1735-1995","1735-7136"],"issn-type":[{"value":"1735-1995","type":"print"},{"value":"1735-7136","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-04-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}